These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1414688)

  • 1. Inhaled budesonide regimen enhances serotonin- and arachidonic acid-induced platelet aggregation.
    Hasselmark L; Malmgren R; Dumitrescu A
    Agents Actions; 1992 May; 36(1-2):44-9. PubMed ID: 1414688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man.
    Nieminen MM; Moilanen EK; Koskinen MO; Karvonen JI; Tuomisto L; Metsä-Ketelä TJ; Vapaatalo H
    Br J Clin Pharmacol; 1992 Jun; 33(6):645-52. PubMed ID: 1327049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid.
    Kornblihtt LI; Finocchiaro L; Molinas FC
    J Pineal Res; 1993 May; 14(4):184-91. PubMed ID: 8345446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide.
    Nikolaizik WH; Marchant JL; Preece MA; Warner JO
    Am J Respir Crit Care Med; 1996 Jan; 153(1):97-101. PubMed ID: 8542169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism interaction between arachidonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways.
    Saeed SA; Rasheed H; Gilani AU
    Acta Pharmacol Sin; 2003 Oct; 24(10):958-64. PubMed ID: 14531936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an inhaled corticosteroid on airway eosinophils and allergen-induced airway hyperresponsiveness in dogs.
    Woolley MJ; Wattie J; Ellis R; Lane CG; Stevens WH; Woolley KL; Dahlback M; O'Byrne PM
    J Appl Physiol (1985); 1994 Sep; 77(3):1303-8. PubMed ID: 7836134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ; Clark RA; Lipworth BJ
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].
    Shenkman B; Einav Y; Salomon O; Varon D; Savion N
    Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study assessing inhaled budesonide in chronically oxygen-dependent infants.
    Giffin F; Greenough A
    Acta Paediatr; 1994 Jun; 83(6):669-71. PubMed ID: 7919769
    [No Abstract]   [Full Text] [Related]  

  • 13. Asthma, inhaled corticosteroid treatment, and growth.
    Ninan TK; Russell G
    Arch Dis Child; 1992 Jun; 67(6):703-5. PubMed ID: 1626989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of cyclooxygenase and signalling inhibitors on 5-hydroxytryptamine- and epinephrine-induced platelet activation.
    Saeed SA; Rasheed H; Gilani AH; Hashmi A; Shah BH
    Proc West Pharmacol Soc; 2001; 44():159-62. PubMed ID: 11793969
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.
    Laitinen LA; Laitinen A; Haahtela T
    J Allergy Clin Immunol; 1992 Jul; 90(1):32-42. PubMed ID: 1629507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled budesonide therapy for patients with stable COPD.
    Weiner P; Weiner M; Azgad Y; Zamir D
    Chest; 1995 Dec; 108(6):1568-71. PubMed ID: 7497762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
    Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
    Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1992 Jan; 33(1):25-31. PubMed ID: 1540486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.